Ketamine shows promise for rapid relief of suicidal ideation

NCT ID NCT02299440

Completed Symptom relief Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Dec 10, 2025 · Last updated May 15, 2026 · Updated 20 times

Summary

This study tested whether ketamine, given as two infusions, can quickly reduce suicidal thoughts in 156 patients hospitalized for suicide risk. The main goal was to see if suicidal ideas resolved within 24 hours after the second dose. The approach aims to provide fast, short-term relief during a crisis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

APHP - Hôpital Lariboisière

Paris, 75010, France
CHRU de Lille - Hôpital Michel Fontan

Lille, 59037, France
CHRU de Montpellier - Hôpital Lapeyronie

Montpellier, 34295, France
CHRU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, 30029, France
CHRU de Tours - Clinique Psychiatrique Universitaire

Saint-Cyr-sur-Loire, 37540, France
CHU de Clermont Ferrand - Hôpital Gabriel-Montpied

Clermont-Ferrand, 63003, France
CMME Centre Hospitalier Sainte Anne

Paris, 75674, France
Centre Hospitalier Sainte-Anne

Paris, 75674, France
Clinique Les Sophoras

Nîmes, 30000, France

Conditions

Explore the condition pages connected to this study.

SUICIDAL IDEATION